INTRODUCTION
Pain is a most common symptom of any illness. The international association for the study of Pain's widely used definition states: "Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage".
Non-steroidal anti-inflammatory drugs (NSAIDs) have been advocated to provide "multimodal" or "balanced" analgesia that decreases opioid dose requirements and may reduce related adverse events while reducing postoperative pain. Paracetamol (acetaminophen) is one of the most popular and most commonly used analgesic and antipyretic drug around the world, the drug of choice in patients who cannot be treated with NSAIDs, such as bronchial asthma, peptic ulcer disease, hemophilia, and salicylate-sensitization, children under 12 years of age, pregnant or breastfeeding women. 5, 6 It is a poor inhibitor of prostaglandins (PG) synthesis in peripheral tissues, but more active on cyclooxygenase (COX) in the brain. It raises pain threshold and its ability to inhibit COX-3 could also account for its analgesic-antipyretic action. In contrast to other NSAIDs, paracetamol does not stimulate respiration or affect acid-base balance and does not increase cellular metabolism. It has no effect on cardiovascular system (CVS). Gastric irritation is insignificant mucosal erosion and bleeding occurs rarely. It does not affect platelet function or clotting factors and is not uricosuric. 6, 7 Diclofenac is one of the most extensively used NSAID; employed in rheumatoid and osteoarthritis, bursitis, ankylosing spondylitis, toothache, dysmenorrhoea, renal colic, posttraumatic and postoperative inflammatory conditions. The mechanism of action of diclofenac goes beyond COX inhibition and include inhibition of thromboxane-prostanoid receptor, affecting arachidonic acid release and uptake, inhibition of lipoxygenase enzymes and activation of the nitric oxide-cyclic guanosine monophosphate anti-nociceptive pathway. 6, 8 But it has shown to increase the risk of heart attack, stroke and reversible elevation of serum aminotransferases apart from its regular gastrointestinal (GI) side effects like epigastric pain, nausea and even headache, dizziness, rashes, etc. 6, 7 Post-operative pain control is an issue dealt with in recent years. Sincere efforts are of utmost importance as effective pain relief is a main objective to modify surgical stress responses, thereby leading to an improved outcome. 4, 5 The opioid sparing effect of NSAIDs has often been used as an analgesic efficacy parameter. Several research and review studies have concluded that the combination of paracetamol with widely used NSAIDs proved to be synergistic and provide superior analgesia than either drug alone. 4, 9, 10 But the research work on paracetamol as single analgesic agent for postoperative pain are very minimal and they have got only selected outcomes. Intravenous paracetamol is a newer concept gaining global popularity in acute postoperative pain relief. We consider that the comparison of paracetamol with diclofenac in post-operative pain management is important especially as the side effects of these compounds are so different.
Hence, study included other important factors like efficacy, safety and duration of action of paracetamol for the evaluation of postoperative pain in comparison to diclofenac. With these objectives we planned a comparative study of two analgesic drugs paracetamol (IV) and diclofenac (IM).
METHODS

This is a randomized clinical trial conducted in an Institution of Medical Education and Tertiary Care
Centre in Karnataka, India. The study was approved by Institutional Ethics Committee for Humans and trial is registered under Clinical Trial Registry India (CTRI; REF/2015/05/009014). The sample size is calculated on the assumption of a standard deviation (SD) 0.58 of the expected difference from previous studies 3,5 with a power of >80% to detect this difference. The calculated sample size came out as 90 and hence patients were equally assigned in each of group P and group D. The informed consent from all study participants was obtained and the baseline characteristics like age, sex and body mass index (BMI) were noted for comparison. Every patient was individually randomized by envelope method hence had equal opportunity to be in either of the groups.
The patients undergoing elective abdominal surgery between the age group of 18 to 50 years and in the physiological group of American Society of Anaesthesiologist (ASA) I & II physical status with no major systemic disease were included in the study. The patients with history of drug allergy to any of the study drug, chronic alcoholism or daily intake of NSAIDS for long time were excluded from the study.
Group D patients received 75 mg/3ml diclofenac IM in gluteal region and Group P patients received 1 g/100ml paracetamol IV (100 ml saline in 15mins) 8 th hourly for 24 hrs post-operative period from the end of surgery. The patients were observed for 24 hrs after surgery. The pain intensity was judged using a 10 point visual analog score (VAS) scale at time periods 2, 4, 6, 12, 18 and 24 hrs after the surgery. Safety and tolerability were evaluated by the occurrence of adverse events, especially the incidence and severity of gastrointestinal symptoms. If a patient reported a VAS pain score of greater than 3, a rescue analgesic in the form of IV tramadol 100 mg injection was given. The need of rescue analgesic was recorded for both the groups at time periods 2, 4, 6, 12, 18 and 24 h after surgery. 2, 4 The primary outcome of our study was VAS until first rescue analgesic request and the requirement of rescue analgesic in the form of injection tramadol over 24 hrs. The secondary outcomes measured was patient satisfaction score (PSC) till rescue analgesic was given and adverse events. VAS was measured on a scale from 0 to 10 and rescue analgesic was administered at any score greater than 3. PSC was assessed using a four point rating scale (poor = 0, fair =1, good=2 and excellent=3).
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Statistical analysis
Statistical analysis was performed using SPSS 17.0 for windows 7 version. Data were expressed as mean values and standard deviation (mean±SD). Data was analyzed using unpaired t test, chi-square test, followed by Fisher's exact test. P<0.05 was considered as statistically significant.
RESULTS
Participants were enrolled and analyzed as shown in Figure 1 . (Consort flow diagram) . Ninety patients were identified by the surgeon and consented for the study. There were 27 men and 18 females in group P and 35 men and 10 females in group D. Both the allocated groups were compared on a number of variables like baseline characteristics, duration of surgery, total tramadol requirement and number of patients requiring rescue analgesics to ensure adequate randomization; the comparisons are shown in Table 1 and did not differ significantly. The data were expressed in the form of mean±SD. Pain intensity in the form of post-operative pain VAS score were shown in Table 2 . VAS score was zero on 2nd hour post operatively and the mean of VAS score recorded at 4 th , 6 th , 12 th , 18 th and 24 th hr showed no significant difference between the two groups (p value >0.05). The same was tabulated and shown in the Figure 2 . Tramadol requirement during 24 hr was 600 mg in group P and 400 mg in group D. There was no clinical or statistical difference between both groups of patients requiring rescue analgesic. Patient satisfaction score (PSC) till administration of rescue analgesic were represented in Table 2 and Figure  3 , which depicts there is statistically significant difference between the groups (*p=0.043). Good PSC score is appreciably more with group P when compared to group D. Patient satisfaction is an important indicator of quality of care because of its relevance to compliance and better patient outcome. Side effects occurred in small fraction i.e. nausea occurred in 8.8% of the participants in group D and 4.4% among group P. Vomiting occurred among 17.8% of group D participants (p= 0.108) and 6.7% among group P participants (p = 0.398) respectively and were not statistically significant. In general, no clinically significant changes in vital signs or laboratory values or no major adverse drug reactions to the drugs were noted in our study. 
DISCUSSION
All surgical procedures will produce pain of variable intensity. Post-operative pain of severe intensity is implicated in respiratory excursion, atelectasis and also prolong gastroileus, urinary retention, increased risk of deep vein thrombosis. 12 It is also well known that the increased level of catecholamine due to surgery will in turn increase in myocardial work and oxygen consumption. The introduction of NSAIDs has decreased the use of narcotics and is useful in patients who are tolerant to opiates and in elder patients. Narcotic analgesics have limitations like respiratory depression or narcotic addiction, so most of clinicians do not prefer to prescribe them. 1, 12, 13 In our study, the statistical results across the study groups showed that the primary outcome measure i.e. pain VAS score and the requirement of rescue analgesics did not show clinically or statistically significant difference between paracetamol and diclofenac groups. But both showed an opioid sparing effect approximately up to 90% (91.2% and 88.9% respectively in paracetamol and diclofenac groups) in patient controlled analgesia. It's known that paracetamol gives more reliable therapeutic plasma concentrations when given intravenously and paracetamol can be a practicable alternative to diclofenac especially because of low incidence of adverse effects, better compliance and can be a preferred choice in high risk patients.
There are multiple measures available to assess pain in adult patients. Pain VAS is a unidimensional single item known for its simplicity and adaptability that provide an estimate of pain intensity in patients both in terms of quantity and quality. 11 The pain VAS has found to be more reliable and accepted by our patients and showed sensitivity to changes in pain assessed hourly during research.
Even if the number of adverse events were low in both treatment groups, there is a trend toward a reduction in GI symptoms with paracetamol, as suggested by a reduced incidence of gastrointestinal side effects (6.6% of patients compared with 17.7% in the diclofenac group) that did not reach statistical significance. The reported adverse effects like nausea and vomiting were more with diclofenac group. During interpretation of our findings related to side effects, we were very careful in differentiating these side effects from that of residual effects of anesthesia and surgery. Other less expected side effects mentioned in earlier studies like allergy, hypotension, hepatotoxicity, altered blood count, etc were not found in any patients enrolled in this study.
Pal et al. in their study of 102 patients undergoing lower abdominal gynaecological surgery compared paracetamol (1 gm/100ml) IV, diclofenac (75 mg/3ml) IM and combination of both. They found that the diclofenac and its combination with paracetamol showed better efficacy when compared to paracetamol alone in terms of the requirement of rescue analgesics. 5 Nath et al, studied the effect of IV paracetamol in comparison to IV tramadol for patients undergoing lower abdominal surgery and found that the iv paracetamol can be better alternative to tramadol in terms of efficacy and safety. 3 Two different studies done on patients undergoing elective gynaecological surgeries compared paracetamol, diclofenac and their combination; gives two different results, one showing combination is better with 40% decrease in pain intensity, another showed no significant difference in pain intensity among groups. 14, 15 Very few studies state that the analgesic efficacy of intravenous paracetamol was comparable and superior to that of tramadol or diclofenac which are standard postoperative analgesics used for abdominal surgery.
Study limitations were that blinding was not possible because of different routes of drug administration and it may need large sample size to generalize the results.
